{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:08:59Z","timestamp":1767650939805},"reference-count":44,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2003,4,28]],"date-time":"2003-04-28T00:00:00Z","timestamp":1051488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prenatal Diagnosis"],"published-print":{"date-parts":[[2003,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cystic fibrosis is a serious disorder. Research into the treatment of affected individuals is in progress, but a cure is not expected in the near future. In this review, we demonstrate that prenatal screening for cystic fibrosis meets the requirements for a worthwhile screening programme. We explain the reasons that have led us to conclude that one approach (\u2018couple screening\u2019) is the method of choice. The couple\u2010based approach calls for reporting results to the couple as a unit. Only if both parents are found to be carriers is the result designated screen\u2010positive and an amniocentesis or chorionic villus sampling offered. This offers a substantial reduction in the proportion of women with unaffected pregnancies with positive results (the false\u2010positive rate) compared with other methods without reducing the detection of affected pregnancies. It also avoids creating a screen\u2010positive group for which no definitive diagnosis is available. This is a problem with other screening methods. The couple method can achieve a 72% detection rate for a 0.1% false\u2010positive rate. The screening method is simple, non\u2010invasive, reliable, safe and reasonably cost effective. Existing programmes have shown that screening using this method is acceptable to health care professionals and patients. Setting up a national prenatal screening programme for cystic fibrosis is timely and should be implemented using the couple screening method. Copyright \u00a9 2003 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/pd.618","type":"journal-article","created":{"date-parts":[[2003,6,13]],"date-time":"2003-06-13T10:10:34Z","timestamp":1055499034000},"page":"474-483","source":"Crossref","is-referenced-by-count":18,"title":["Cystic fibrosis: selecting the prenatal screening strategy of choice"],"prefix":"10.1002","volume":"23","author":[{"given":"N. J.","family":"Wald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. K.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. H.","family":"Rodeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Haddow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. E.","family":"Palomaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,4,28]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"951","article-title":"Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1 : 29 in the Jewish Ashkenazi population","volume":"32","author":"Abeliovich D","year":"1992","journal-title":"Am J Hum Genet"},{"key":"e_1_2_1_3_1","unstructured":"American College of Obstetricians and Gynecologists American College of Medical Genetics.2001.Preconception and Prenatal Carrier Screening for Cystic Fibrosis: Clinical and Laboratory Guidelines Washington DC ACOG."},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6892.1584"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.68.1.120"},{"key":"e_1_2_1_6_1","first-page":"1599","article-title":"Cystic fibrosis in the United Kingdom 1977\u201385; an improving picture","volume":"197","author":"British Paediatric Association Working Party on Cystic Fibrosis","year":"1988","journal-title":"BMJ"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90340-2"},{"key":"e_1_2_1_8_1","volume-title":"Antenatal and Neonatal Screening","author":"Brock DJH","year":"2000"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.7018.1460"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.30.2.164"},{"key":"e_1_2_1_11_1","unstructured":"Cystic Fibrosis Foundation.2000.Patient Registry 1994 Annual Report Bethesda MD."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.1380040302"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0223(199605)16:5<397::AID-PD864>3.0.CO;2-I"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.46.12.881"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.0.CO;2-J"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710023371403"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1542\/peds.107.1.1","article-title":"Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves longterm growth","volume":"107","author":"Farrell PM","year":"2001","journal-title":"Pediatrics"},{"key":"e_1_2_1_18_1","first-page":"57","article-title":"A correction of the estimates of the least common cystic fibrosis (CF) mutations published by the Cystic Fibrosis Genetic Analysis Consortium in 1994","volume":"11","author":"Georgi S","year":"1997","journal-title":"Gene Geograph"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/096914139700400101","article-title":"Why the term \u201ccarrier screening\u201d should be abandoned","volume":"4","author":"Haddow JE","year":"1997","journal-title":"J Med Screen"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70441-X"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00207378"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000472174"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.308.6942.1459"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(99)70454-0"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0223(199709)17:9<853::AID-PD151>3.0.CO;2-3"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001402"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6976.353"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3310\/hta3080","article-title":"Screening for cystic fibrosis","volume":"3","author":"Murray J","year":"1999","journal-title":"Health Technol Assess"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00125817-200203000-00007"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.1997.tb02445.x"},{"key":"e_1_2_1_31_1","first-page":"433","article-title":"Cystic fibrosis mutations among African Americans in the southeastern United States","volume":"87","author":"Philips OP","year":"1995","journal-title":"J Nat Med Assoc"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1996.02170300108024"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.47.9.684"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.302.6785.1133"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0954-6111(05)80065-4"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/00125817-200207000-00007"},{"key":"e_1_2_1_37_1","first-page":"626","article-title":"Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization","volume":"55","author":"Tambor ES","year":"1994","journal-title":"Am J Hum Genet"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92605-2"},{"key":"e_1_2_1_39_1","first-page":"195","volume-title":"Turnbull's Obstetrics","author":"Wald NJ","year":"1995"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.310.6988.1199a"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0223(199602)16:2<143::AID-PD825>3.0.CO;2-F"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92403-G"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/pd.1970150615"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908123410701"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.303.6801.504"}],"container-title":["Prenatal Diagnosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpd.618","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pd.618","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T17:41:48Z","timestamp":1696700508000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1002\/pd.618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,28]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["10.1002\/pd.618"],"URL":"https:\/\/doi.org\/10.1002\/pd.618","archive":["Portico"],"relation":{},"ISSN":["0197-3851","1097-0223"],"issn-type":[{"value":"0197-3851","type":"print"},{"value":"1097-0223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,28]]}}}